- Home
- TOP vs FBIO Comparison
TOP vs FBIO Comparison
Compare TOP & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- FBIO
- Stock Information
- Founded
- TOP 2015
- FBIO 2006
- Country
- TOP Hong Kong
- FBIO United States
- Employees
- TOP N/A
- FBIO N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- TOP Finance
- FBIO Health Care
- Exchange
- TOP Nasdaq
- FBIO Nasdaq
- Market Cap
- TOP 43.3M
- FBIO 49.1M
- IPO Year
- TOP 2022
- FBIO N/A
- Fundamental
- Price
- TOP $1.21
- FBIO $1.86
- Analyst Decision
- TOP
- FBIO Strong Buy
- Analyst Count
- TOP 0
- FBIO 2
- Target Price
- TOP N/A
- FBIO $21.00
- AVG Volume (30 Days)
- TOP 63.2K
- FBIO 227.1K
- Earning Date
- TOP 07-29-2025
- FBIO 08-12-2025
- Dividend Yield
- TOP N/A
- FBIO N/A
- EPS Growth
- TOP N/A
- FBIO N/A
- EPS
- TOP N/A
- FBIO N/A
- Revenue
- TOP $2,730,890.00
- FBIO $57,784,000.00
- Revenue This Year
- TOP N/A
- FBIO $51.59
- Revenue Next Year
- TOP N/A
- FBIO $44.74
- P/E Ratio
- TOP N/A
- FBIO N/A
- Revenue Growth
- TOP N/A
- FBIO N/A
- 52 Week Low
- TOP $1.00
- FBIO $1.33
- 52 Week High
- TOP $1.94
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- TOP 48.13
- FBIO 51.97
- Support Level
- TOP $1.14
- FBIO $1.70
- Resistance Level
- TOP $1.32
- FBIO $2.15
- Average True Range (ATR)
- TOP 0.06
- FBIO 0.10
- MACD
- TOP -0.01
- FBIO -0.01
- Stochastic Oscillator
- TOP 44.33
- FBIO 35.56
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.